Advertisement

Topics

Theraclone Sciences Company Profile

14:14 EDT 20th September 2018 | BioPortfolio

Theraclone Sciences is a Seattle‐based biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. The company’s technology harnesses the power of the human immune system to identify rare, naturally evolved antibodies from the blood cells of immunologically relevant human subjects. Human monoclonal antibodies can be rapidly isolated using the I‐STAR™ discovery platform and scaled for industrial production. Such human antibody drug candidates may be uniquely safe and relevant to combating disease across broad patient populations. Theraclone is a privately held company with venture investment from ARCH Venture Partners, Canaan Partners, Healthcare Ventures, MPM Capital, Amgen Ventures and Alexandria Real Estate Investment. For additional information, please visit www.theraclone-sciences.com.


News Articles [536 Associated News Articles listed on BioPortfolio]

Theraclone Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryTheraclone Sciences Inc Theraclone is a biotech company that develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers development programs o...

Theraclone Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15032018] Prices from USD $250

SummaryTheraclone Sciences Inc Theraclone is a biotech company that develops antibodies for the treatment of cancer. The company develops antibodies that human memory B cells produce naturally in resp...

Almac Sciences: Company Activity and Sharing Risks in Collaborations

In this episode of PharmaTelevision News Review, Fintan Walton talks with Denis Geffroy, Vice President Business Development at Almac Sciences at Almac. Filmed at BioTrinity 2010 in Newbury, UK, they ...

CV Sciences, Inc. Repays Remaining Debt

LAS VEGAS, Aug. 22, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced today that it has fully repaid the pr...

Urovant Sciences files for Nasdaq IPO

Roivant Sciences GMBH's urology-focused subsidiary Urovant Sciences Ltd. filed for an initial public offering on Nasdaq.

wikifolio whispers p.m. zu Gilead Sciences, Nemetschek, E.ON ...

Gilead Sciences 0.49% DerProfessor (POWREV01): Biotech schwächelt. In diesem Umfeld wird auch GILEAD auf längere Sicht nicht performen. (14.05. 12:11) >> mehr comments zu Gilead Sciences: www.boers....

German Academies of Sciences offer recommendations for the reform of doctoral practices

(Leopoldina) Institutional responsibility for the doctorate at universities must be strengthened. This is the recommendation offered in the statement 'Doctorate in Transition', now available in Englis...

Roivant Launches New China-Based Startup Sinovant Sciences

Fresh off its first Pipeline Day last week, Vivek Ramaswamy’s Roivant Sciences is taking aim at breaking into the Chinese market. Roivant has launched another company called Sinovant Sciences.

Clinical Trials [189 Associated Clinical Trials listed on BioPortfolio]

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [1060 Associated Companies listed on BioPortfolio]

Theraclone Sciences, Inc.

Theraclone Sciences is a Seattle‐based biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. Th...

Theraclone Sciences

Theraclone Sciences is a Seattle‐based biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. Th...

Theraclone Sciences and MD Anderson

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

More Information about "Theraclone Sciences" on BioPortfolio

We have published hundreds of Theraclone Sciences news stories on BioPortfolio along with dozens of Theraclone Sciences Clinical Trials and PubMed Articles about Theraclone Sciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Theraclone Sciences Companies in our database. You can also find out about relevant Theraclone Sciences Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record